a strong trendP = .07
However, in the Stage IV (palliative-intent) cohort ( n = 58), initiating therapy during pregnancy showed a strong trend towards improved survival compared to postpartum initiation (HR = 0.42; 95% CI: 0.17-1.06; P = .07).
However, in the Stage IV (palliative-intent) cohort ( n = 58), initiating therapy during pregnancy showed a strong trend towards improved survival compared to postpartum initiation (HR = 0.42; 95% CI: 0.17-1.06; P = .07).
Although not conventionally significant, the substantial hazard ratio suggests that the survival benefit of antenatal therapy in the overall cohort is driven by patients with advanced disease.